ZA939626B - Pharmaceutical compounds. - Google Patents

Pharmaceutical compounds.

Info

Publication number
ZA939626B
ZA939626B ZA939626A ZA939626A ZA939626B ZA 939626 B ZA939626 B ZA 939626B ZA 939626 A ZA939626 A ZA 939626A ZA 939626 A ZA939626 A ZA 939626A ZA 939626 B ZA939626 B ZA 939626B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Application number
ZA939626A
Other languages
English (en)
Inventor
Didier Vincent Renno
Gerard Bernard O'beirne
Brent Raymond Copp
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of ZA939626B publication Critical patent/ZA939626B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA939626A 1992-12-22 1993-12-22 Pharmaceutical compounds. ZA939626B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929226724A GB9226724D0 (en) 1992-12-22 1992-12-22 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
ZA939626B true ZA939626B (en) 1994-08-18

Family

ID=10727034

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939626A ZA939626B (en) 1992-12-22 1993-12-22 Pharmaceutical compounds.

Country Status (23)

Country Link
US (1) US5565486A (fi)
EP (1) EP0675888A1 (fi)
JP (1) JPH08504804A (fi)
KR (1) KR950704324A (fi)
AU (1) AU677272B2 (fi)
BG (1) BG99736A (fi)
BR (1) BR9307712A (fi)
CA (1) CA2151251A1 (fi)
CZ (1) CZ284121B6 (fi)
FI (1) FI953081A0 (fi)
GB (2) GB9226724D0 (fi)
HU (1) HUT71859A (fi)
IL (1) IL108140A (fi)
MX (1) MX9400174A (fi)
NO (1) NO952483L (fi)
NZ (1) NZ258986A (fi)
PL (1) PL309628A1 (fi)
RU (1) RU95113350A (fi)
SG (1) SG67345A1 (fi)
SK (1) SK77595A3 (fi)
TW (1) TW242141B (fi)
WO (1) WO1994014814A1 (fi)
ZA (1) ZA939626B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070161095A1 (en) * 2005-01-18 2007-07-12 Gurin Michael H Biomass Fuel Synthesis Methods for Increased Energy Efficiency
WO2011133948A2 (en) 2010-04-22 2011-10-27 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
US9789164B2 (en) 2013-03-15 2017-10-17 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348284A (ja) * 1986-08-18 1988-02-29 Yamanouchi Pharmaceut Co Ltd 新抗生物質yp−02908l−aおよびその製造法
ATE69236T1 (de) * 1987-02-06 1991-11-15 Snow Brand Milk Products Co Ltd Neue 7-g(b)-hydroxy-4-pregnen-3,20-dion-derivate und verfahren zur herstellung.
US5120723A (en) * 1987-08-25 1992-06-09 University Of Southern California Method, compositions, and compounds for modulating brain excitability
JP2842613B2 (ja) * 1989-04-28 1999-01-06 塩野義製薬株式会社 フォスフォリパーゼa▲下2▼阻害物質
JPH03108490A (ja) * 1989-06-30 1991-05-08 Shionogi & Co Ltd フォスフォリパーゼa↓2阻害物質
US5130430A (en) * 1990-10-31 1992-07-14 Neurogen Corporation 2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands
US5189050A (en) * 1991-06-03 1993-02-23 Merck & Co., Inc. Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder

Also Published As

Publication number Publication date
TW242141B (fi) 1995-03-01
GB2284603B (en) 1996-03-27
HU9501840D0 (en) 1995-08-28
IL108140A0 (en) 1994-04-12
CZ164695A3 (en) 1995-11-15
BG99736A (bg) 1996-04-30
RU95113350A (ru) 1997-06-10
KR950704324A (ko) 1995-11-17
CZ284121B6 (cs) 1998-08-12
GB9226724D0 (en) 1993-02-17
SK77595A3 (en) 1995-12-06
AU677272B2 (en) 1997-04-17
NZ258986A (en) 1996-11-26
MX9400174A (es) 1994-07-29
US5565486A (en) 1996-10-15
IL108140A (en) 1997-06-10
HUT71859A (en) 1996-02-28
NO952483D0 (no) 1995-06-21
NO952483L (no) 1995-08-15
GB2284603A (en) 1995-06-14
FI953081A (fi) 1995-06-21
AU5709694A (en) 1994-07-19
CA2151251A1 (en) 1994-07-07
JPH08504804A (ja) 1996-05-28
SG67345A1 (en) 1999-09-21
FI953081A0 (fi) 1995-06-21
PL309628A1 (en) 1995-10-30
WO1994014814A1 (en) 1994-07-07
BR9307712A (pt) 1999-08-31
GB9503413D0 (en) 1995-04-12
EP0675888A1 (en) 1995-10-11

Similar Documents

Publication Publication Date Title
EP0670716A4 (en) TASTE-MASKED PHARMACEUTICAL SUBSTANCES.
GR3025363T3 (en) Medicaments.
PH30215A (en) Pharmaceutical compounds
EP0633771A4 (en) Compounds.
HU9303261D0 (en) Pharmaceutical compounds
ZA931944B (en) Pharmaceutical compounds
GB9320051D0 (en) Pharmaceutical compounds
ZA939626B (en) Pharmaceutical compounds.
ZA938546B (en) Pharmaceutical compounds
GB9316923D0 (en) Pharmaceutical compounds
GB9211379D0 (en) Pharmaceutical compounds
GB9314778D0 (en) Pharmaceutical compounds
GB9316912D0 (en) Pharmaceutical compounds
GR1002176B (en) Pharmaceutical substances.
ZA931332B (en) Pharmaceutical compounds
GB9218112D0 (en) Pharmaceutical compounds
GB9218092D0 (en) Pharmaceutical compounds
GB9213058D0 (en) Pharmaceutical compounds
GB9222650D0 (en) Pharmaceutical compounds
GB9226895D0 (en) Pharmaceutical compounds
GB9218090D0 (en) Pharmaceutical compounds
GB9218091D0 (en) Pharmaceutical compounds
GB9209028D0 (en) Pharmaceutical compounds
ZA93692B (en) Arylalkoxyphenoxy-imidazoline compounds.
ZA932264B (en) Compounds.